Alvotech (NASDAQ:ALVO) is one of the best oversold NASDAQ stocks to buy now. On July 9, Alvotech (NASDAQ:ALVO) announced that ...

Ivers-Lee’s assembly and packaging capabilities will be integrated into Alvotech's Technical Operations division.

Alvotech stock has dropped despite strong fundamentals and rapid sales growth. Read about ALVO's projected revenue, debt ...

Alvotech acquires Swiss packaging firm Ivers-Lee to boost biosimilar production capacity ahead of three 2025 launches.

Alvotech (ALVO) has been on a downward spiral lately with significant selling pressure. After declining 6.6% over the past ...

Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, has appointed Linda ...

Max Kettner, chief multi-asset strategist at HSBC, appeared on CNBC to talk about the global markets amid trade tensions.

Alvotech ( NASDAQ: ALVO) is expanding its capacity for assembly and packaging with the acquisition of Ivers-Lee Group. Based in Burgdorf, Switzerland, Ivers-Lee provides assembly and packaging ...

Teva Pharmaceutical Industries Limited’s TEVA shares have risen 21.6% in three months. Over the past few quarters, Teva has ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a ...

Alvotech and Advanz Pharma expand their European biosimilar partnership to include AVT10, targeting Cimzia® for rheumatic ...

Alvotech, Kashiv, and Advanz announce successful efficacy study results for AVT23, a proposed biosimilar to Xolair® for CSU treatment.